No abstract available
Keywords:
coronary artery disease; hypertension; risk factors.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Antiviral Agents / adverse effects
-
Antiviral Agents / therapeutic use*
-
Betacoronavirus / drug effects*
-
Betacoronavirus / pathogenicity
-
COVID-19
-
COVID-19 Drug Treatment
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / drug therapy*
-
Coronavirus Infections / epidemiology
-
Coronavirus Infections / virology
-
Enzyme Replacement Therapy* / adverse effects
-
Hemodynamics / drug effects*
-
Host-Pathogen Interactions
-
Humans
-
Pandemics
-
Peptidyl-Dipeptidase A / adverse effects
-
Peptidyl-Dipeptidase A / deficiency
-
Peptidyl-Dipeptidase A / genetics
-
Peptidyl-Dipeptidase A / therapeutic use*
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / drug therapy*
-
Pneumonia, Viral / epidemiology
-
Pneumonia, Viral / virology
-
Renin-Angiotensin System / drug effects*
-
Renin-Angiotensin System / genetics
-
SARS-CoV-2
-
Severity of Illness Index
-
Treatment Outcome
Substances
-
Antiviral Agents
-
ACE protein, human
-
Peptidyl-Dipeptidase A